+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market 2021-2025- Product Image

Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market 2021-2025

  • ID: 5305725
  • Report
  • March 2021
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Apotex Inc.
  • Aurobindo Pharma Ltd.
  • Cipla Inc.
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • MORE
Global Selective Serotonin Reuptake Inhibitors (SSRIS) Market 2021-2025

The publisher has been monitoring the selective serotonin reuptake inhibitors (SSRIS) market and it is poised to grow by $ 809.73 mn during 2021-2025 progressing at a CAGR of 4% during the forecast period. The reports on selective serotonin reuptake inhibitors (SSRIS) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of mental illnesses and increased drug dependency associated with SSRIs and favorable drug purchasing policies for patients. In addition, rising prevalence of mental illnesses is anticipated to boost the growth of the market as well.

The selective serotonin reuptake inhibitors (SSRIS) market analysis includes application segment and geographical landscapes .

The selective serotonin reuptake inhibitors (SSRIS) market is segmented as below:

By Application
  • Depression
  • Anxiety And Panic Disorder
  • Other Mental Conditions
By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the growing geriatric population as one of the prime reasons driving the selective serotonin reuptake inhibitors (SSRIS) market growth during the next few years. Also, lack of R&D in neuropsychopharmacology and rising government initiatives will lead to sizable demand in the market.

The report on selective serotonin reuptake inhibitors (SSRIS) market covers the following areas:
  • Selective serotonin reuptake inhibitors (SSRIS) market sizing
  • Selective serotonin reuptake inhibitors (SSRIS) market forecast
  • Selective serotonin reuptake inhibitors (SSRIS) market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading selective serotonin reuptake inhibitors (SSRIS) market vendors that include AbbVie Inc., Apotex Inc., Aurobindo Pharma Ltd., Cipla Inc., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck AS, Lupin Ltd., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.. Also, the selective serotonin reuptake inhibitors (SSRIS) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Apotex Inc.
  • Aurobindo Pharma Ltd.
  • Cipla Inc.
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Application
  • Market segments
  • Comparison by Application
  • Depression - Market size and forecast 2020-2025
  • Anxiety and panic disorder - Market size and forecast 2020-2025
  • Other mental conditions - Market size and forecast 2020-2025
  • Market opportunity by Application
Customer landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Apotex Inc.
  • Aurobindo Pharma Ltd.
  • Cipla Inc.
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • H. Lundbeck AS
  • Lupin Ltd.
  • Pfizer Inc.
  • Takeda Pharmaceutical Co. Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Depression - Market size and forecast 2020-2025 ($ million)
  • Depression - Year-over-year growth 2020-2025 (%)
  • Anxiety and panic disorder - Market size and forecast 2020-2025 ($ million)
  • Anxiety and panic disorder - Year-over-year growth 2020-2025 (%)
  • Other mental conditions - Market size and forecast 2020-2025 ($ million)
  • Other mental conditions - Year-over-year growth 2020-2025 (%)
  • Customer landscape
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Business segments
  • AbbVie Inc. - Key offerings
  • AbbVie Inc. - Key customers
  • AbbVie Inc. - Segment focus
  • Apotex Inc. - Overview
  • Apotex Inc. - Product and service
  • Apotex Inc. - Key offerings
  • Apotex Inc. - Key customers
  • Apotex Inc. - Segment focus
  • Aurobindo Pharma Ltd. - Overview
  • Aurobindo Pharma Ltd. - Product and service
  • Aurobindo Pharma Ltd. - Key offerings
  • Aurobindo Pharma Ltd. - Key customers
  • Aurobindo Pharma Ltd. - Segment focus
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Key customers
  • Cipla Inc. - Segment focus
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Business segments
  • Eli Lilly and Co. - Key offerings
  • Eli Lilly and Co. - Key customers
  • Eli Lilly and Co. - Segment focus
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Key customers
  • GlaxoSmithKline Plc - Segment focus
  • H. Lundbeck AS - Overview
  • H. Lundbeck AS - Business segments
  • H. Lundbeck AS - Key offerings
  • H. Lundbeck AS - Key customers
  • H. Lundbeck AS - Segment focus
  • Lupin Ltd. - Overview
  • Lupin Ltd. - Product and service
  • Lupin Ltd. - Key offerings
  • Lupin Ltd. - Key customers
  • Lupin Ltd. - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product and service
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Takeda Pharmaceutical Co. Ltd. - Key customers
  • Takeda Pharmaceutical Co. Ltd. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Apotex Inc.
  • Aurobindo Pharma Ltd.
  • Cipla Inc.
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • MORE
The publisher recognizes the following companies as the key players in the global selective serotonin reuptake inhibitors (ssris) market: AbbVie Inc., Apotex Inc., Aurobindo Pharma Ltd., Cipla Inc., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck AS, Lupin Ltd., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing geriatric population.'

According to the report, one of the major drivers for this market is the rising prevalence of mental illnesses.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • AbbVie Inc.
  • Apotex Inc.
  • Aurobindo Pharma Ltd.
  • Cipla Inc.
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • H. Lundbeck AS
  • Lupin Ltd.
  • Pfizer Inc.
  • Takeda Pharmaceutical Co. Ltd.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll